Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
XBI
XBI
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
XBI News
REPL Stock Poised for Largest Decline in Almost 7 Months Before FDA Decision on Skin Cancer Treatment
6d ago
stocktwits
IBRX Stock Poised for Breakout Quarter: Anktiva Launches Phase 2 Long COVID Trial Amid European Expansion Plans
Mar 30 2026
stocktwits
ALT Stock Has Dropped Nearly 50% Over the Last Year, Yet Wall Street Predicts Nearly 500% Growth Potential.
Mar 27 2026
stocktwits
AVXL Shares Plummet as Anavex Cancels EU Application for Alzheimer's Treatment
Mar 25 2026
stocktwits
Major Test for the IPO Market This Week as Multiple Unicorns Prepare to Launch.
Feb 03 2026
Barron's
IBRX Stock Gains Retail Enthusiasm Following Saudi FDA Approval of Company's Bladder Cancer Immunotherapy
Jan 14 2026
stocktwits
Moderna Stock's Strong Performance is Just the Start: A Technical Analysis
Jan 13 2026
Barron's
'Biotech Super Bowl' Fizzles as Stocks Drop Amid Absence of Deal Announcements.
Jan 12 2026
Barron's
Biotech and Pharma Shares Drop as Investors Shift Focus to Energy Sector
Jan 05 2026
Barron's
UnitedHealth Focuses on Recovery Alongside Four Key Healthcare Stock Trends to Monitor in 2026
Dec 28 2025
Barron's
Mergers and Acquisitions Reached New Heights This Year: Stocks Poised for Greater Growth in 2026.
Dec 23 2025
Barron's
State Street® SPDR® S&P® Biotech ETF announces dividend of $0.4066
Dec 22 2025
SeekingAlpha
ETF Outflow Warning: XBI, EXAS, RVMD, RNA
Dec 11 2025
NASDAQ.COM
Biotech ETF (XBI) Reaches Record 52-Week Peak
Dec 05 2025
NASDAQ.COM
Former FDA Leaders Push Back Against Recent Changes at the Agency
Dec 04 2025
Barron's
The Biotech Sector Is Stronger Than Investors Realize: Key Stocks to Monitor.
Dec 04 2025
Barron's
Show More News
